VoluMetrix, a biotech startup focused on vital monitoring, announced the FDA granted its venous waveform monitoring device a breakthrough device designation. According to a press release, the ...

July 15, 2020 -The first consensus-based nomenclature for arterial and venous waveforms has been published online first today in Vascular Medicine (VMJ) and the Journal for Vascular Ultrasound (JVU).

The primary purpose of the cardiac examination is to assess the structure and function of the heart as a muscular pump and to evaluate it for possible malfunctions. Because heart disease is so common ...

The FDA granted breakthrough device designation to Volumetrix LLC for its NIVAHF monitoring system for heart failure. The device is the first application of the company’s noninvasive venous waveform ...